Advertisement for orthosearch.org.uk
Results 1 - 7 of 7
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 102-B, Issue SUPP_10 | Pages 56 - 56
1 Oct 2020
Lombardi AV Berend KR Huddleston J Crawford D Peters C VanAndel D Anderson M DeHaan A Southgate R Duwelius PJ
Full Access

Background

The purpose of this study is to evaluate the early outcomes with the use of a smartphone-based exercise and educational platform after primary total hip arthroplasty compared to a standard of care control group.

Methods

A multicenter prospective randomized control trial was conducted evaluating the use of the mymobility smartphone-based care platform for primary total hip arthroplasty (THA). Patients randomized to the control group (198 patients) received the respective institution's standard of care. Those randomized to mymobility treatment group (167 patients) were provided an Apple Watch and mymobility smartphone application. The application provides pre and postoperative educational content, video directed exercise programs as well as tracks the patient's activity. Patients in the treatment group were not initially prescribed physical therapy, but could be if their surgeon deemed it necessary. Early outcomes assessed included 90-day hip range of motion, HOOS JR scores, 30-day single leg stance (SLS) and time up and go (TUG) test.

We also evaluated PT utilization, THA complications associated with readmissions, ER visits not associated with readmissions, urgent care (non standard of care) visits, and physician office visits.

Outcome scores include HOOS-Jr, EQ-5D-5L, single stance (SLS), Timed up and go (TUG).

Satisfaction scores for the procedure and the mymobility study group were also recorded.


Orthopaedic Proceedings
Vol. 102-B, Issue SUPP_9 | Pages 7 - 7
1 Oct 2020
Goswami K Clarkson S Dennis DA Klatt BA O'Malley M Smith EL Pelt CE Gililland J Peters C Malkani AL Palumbo B Minter J Goyal N Cross M Prieto H Lee G Hansen E Ward D Bini S Higuera C Levine B Nam D Della Valle CJ Parvizi J
Full Access

Introduction

Surgical management of PJI remains challenging with patients failing treatment despite the best efforts. An important question is whether these later failures reflect reinfection or the persistence of infection. Proponents of reinfection believe hosts are vulnerable to developing infection and new organisms emerge. The alternative hypothesis is that later failure is a result of an organism that was present in the joint but was not picked up by initial culture or was not a pathogen initially but became so under antibiotic pressure. This multicenter study explores the above dilemma. Utilizing next-generation sequencing (NGS), we hypothesize that failures after two stage exchange arthroplasty can be caused by an organism that was present at the time of initial surgery but not isolated by culture.

Methods

This prospective study involving 15 institutions collected samples from 635 revision total hip (n=310) and knee (n=325) arthroplasties. Synovial fluid, tissue and swabs were obtained intraoperatively for NGS analysis. Patients were classified per 2018 Consensus definition of PJI. Treatment failure was defined as reoperation for infection that yielded positive cultures, during minimum 1-year follow-up. Concordance of the infecting pathogen cultured at failure with NGS analysis at initial revision was determined.


Orthopaedic Proceedings
Vol. 100-B, Issue SUPP_17 | Pages 63 - 63
1 Dec 2018
Dusane D Peters C Laycock P Aiken S Stoodley P
Full Access

Aim

Carbapenem-resistant Enterobacteriaceae (CRE) and vancomycin resistant Enterococci (VRE) have emerged as multi-drug resistant Gram-negative pathogens associated with Periprosthetic Joint Infections (PJI). In this study, we evaluated the efficacy of antibiotic-loaded calcium sulfate beads (ABLCB) to inhibit bacterial growth, biofilm formation and eradicate preformed biofilms of K. pneumoniae and E. faecalis.

Method

Three strains of K. pneumoniae (carbapenem resistant BAA1705, New Delhi metallo-beta-lactamase producing BAA2146 [NDM-1], a carbapenemase producing BAA2524) and a vancomycin resistant strain of E. faecalis (ATCC51299) were used. 4.8mm diameter ABLCBs (Stimulan Rapid Cure, Biocomposites) were loaded with vancomycin (VAN) & gentamicin (GEN) at 500 and 240 mg/10cc pack or VAN & rifampicin (RIF) at 1000 and 600 mg/10cc pack respectively and placed onto tryptic soy agar (TSA) plates spread with each of the four strains independently and incubated for 24 hours at 37°C. The beads were transferred daily onto fresh TSA medium spread with the test cultures. The zone of inhibition was recorded until no inhibition was observed. Biofilm prevention efficacy was investigated in 6 well plates. Bacterial cells (5×105 CFU/mL in tryptic soy broth) were treated with ABLCBs. Media was removed and challenged with bacteria daily for 7 days. CFU counts were taken after 1, 2, 3 and 7 days. For biofilm killing, ABLCB were added to 3 day formed biofilms in 6 well plates. CFU counts were estimated at 1, 3 and 7 days with daily media exchange.


Orthopaedic Proceedings
Vol. 100-B, Issue SUPP_1 | Pages 50 - 50
1 Jan 2018
Makarewich CA Christensen M Anderson M Gililland J Pelt C Peters C
Full Access

Total hip arthroplasty (THA) in the young patient has been associated with higher rates of revision and perioperative complications. For clinicians and patients alike, there remains a desire to better characterize the durability of THA in young patients. We reviewed secondary data from our institutional database for all patients who underwent primary THA from January 2000 to May 2015. Patients were identified using ICD-9 procedure code 81.51. Our primary interest was the survival of implants in patients 30 years of age or younger (n=167) while using a contemporaneous cohort of patients age 60 and older as a control (n=1359). Failure was defined as revision THA for any reason. Cox regression with robust standard errors was used to calculate hazard ratios. A population-averaged Poisson regression analysis was used to compare complication rates.

The rate of all-cause revision THA was 2.4 times greater (95% CI 1.10 – 5.37, p=0.028) in young patients (7%, 12/167) undergoing primary or conversion to THA compared to their elderly counterparts (3.7%, 50/1,359). Survival at 10 years was 89% (95% CI 82 – 94) in the young cohort and 96% (94 – 97) in the elderly cohort. The primary reasons for revision in young that patients compared to their elderly counterparts included metal-on-metal implants (IRR 8.12, 95% CI 2.04 – 32.38, p=0.003).

These data demonstrate that patients 30 years of age and younger substantially benefit from THA but should be warned of higher risk of subsequent revision.


Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_7 | Pages 140 - 140
1 May 2016
Frisch N Scotting O Mehran N Peters C Silverton C
Full Access

Introduction

Total knee arthroplasty (TKA) is the definitive treatment for osteoarthritis of the knee. The primary goal of the operation is to minimize or eliminate pain associated with osteoarthritis and secondarily to regain functional mobility and stability around the knee joint in order improve overall quality of life. The vast majority of techniques utilized for this procedure involves removal of the anterior cruciate ligament (ACL). In a native knee the ACL is a primary stabilizing ligament and essential for providing proprioceptive feedback. In the absence of the ACL, the kinematics of the knee are compromised. In an effort to more accurately replicate normal knee stability, new implant designs have emerged which maintain an intact ACL. Described herein is a cadaveric study looking at ACL competency after implantation of a TKA in which the cruciate ligaments are preserved.

Methods

Twenty fresh, frozen cadaveric knees were utilized in which the ACL was intact. Specimens were excluded if there was concern for ACL stability as determined by physical examination, direct visualization during the arthrotomy and a KT-1000 measurement of anterior tibial translation in millimeters at 67N and 89N of anterior force. Each KT-1000 measurement was repeated three times using three individual examiners at both force values for a total of six data points. Bicruciate retaining components were implanted into each knee using a medial parapatellar approach. After adequate sagittal and coronal balancing was obtained, the knee was reexamined using the KT-1000 protocol described above to assess for any changes in ACL competency. The ACL was then transected and the knee was examined for a third time with the same KT-1000 protocol. For statistical analysis, a 2-way repeated-measures ANOVA was utilized. Pairwise differences were assessed utilizing Fisher's least significant difference method.


Orthopaedic Proceedings
Vol. 93-B, Issue SUPP_III | Pages 251 - 251
1 Jul 2011
Parvizi J Bican O Bozic K Peters C
Full Access

Purpose: Hip arthroscopy has been used at an increasing frequency over the last few years. Majority of patients undergoing hip arthroscopy are young and active individuals who seek definitive therapy for a painful hip condition and wish to avoid undergoing a hip replacement. Although relatively successful, complications following hip arthroscopy occur. This multi-institutional study presents a worrisome and previously unrecognized complication of hip arthroscopy, namely chondrolysis that lead to accelerated development of end-stage arthritis.

Method: Using the computerized database in each institution, patients undergoing total hip arthroplasty between 1999–2008 who had received hip arthroscopy prior to arthroplasty were identified. 39 patients were identified to have undergone at least one hip arthroscopy on the affected hip prior to arthroplasty. There were 21 female and 18 male patients. The mean age of patients at the time of hip arthroscopy was 45.9 years. Data regarding demographics, comorbidities, preoperative diagnosis, number of previous procedures, and the details of the surgical procedure were compiled. Radiographs were evaluated.

Results: The median time from arthroscopy to arthroplasty was 14.8 months (range 2.2 months to 7 years). Fourteen patients (35%) underwent THA within 12 months of a previous hip arthroscopy and in nine of these patients the indication for hip arthroscopy was labral tear debridement. These patients despite having none to minimal arthritis at the time of arthroscopy developed accelerated arthritis within a year that necessitated hip replacement.

Conclusion: Hip arthroscopy can cause accelerated degenerative arthritis of the hip in some patients. We believe the subset of our patients who developed arthritis so early after hip arthroscopy may have suffered chondrolysis and/or chondral injury during the arthroscopy that resulted in progressive and aggressive arthritis of the hip within 12 months. Hip arthroscopy should be reserved for a select group of patients. All measures to minimize the possibility of chondrolysis and/or chondral injury should be exercised.


Orthopaedic Proceedings
Vol. 90-B, Issue SUPP_III | Pages 531 - 531
1 Aug 2008
Nolan JF Darrah C Donell ST Wimhurst J Toms A Marshall T Barker T Case CP Peters C Tucker JK
Full Access

60 out of total series of 643 metal-on-metal hip replacements, carried out over the last nine years, have so far required revision, 13 for peri-prosthetic fracture and 47 for extensive, symptomatic, peri-articular soft-tissue changes.

Dramatic corrosion of generally solidly fixed, cemented stems has been observed and is believed to have resulted in the release of high levels of cobalt chrome ions from the stem surface. The contribution of the metal-to-metal articulation is, as yet, unclear.

Not including the fracture cases, plain films have demonstrated little or no abnormality to account for patients’ progressive symptoms. MRI scanning, on the other hand, utilising a technique designed to minimise implant artefact, has correlated very closely with findings at the time of revision surgery.

The histological changes, typified by extensive lymphocytic infiltration and a severe vasculitis leading to, in some cases, extensive tissue necrosis are demonstrated and discussed.

The failure of any of the existing protective mechanisms or regulatory restrictions to identify and limit the exposure of large numbers of patients to unsatisfactory implants has again been demonstrated.